IA
AST

IFP Advisors’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

IFP Advisors’s Portfolio AST Stock Details AST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,518
Closed -$1K – 4009
2018
Q4 		$1K Sell
1,518
-1,147
-43% -$1.19K ﹤0.01% 3484
2018
Q3 		$3K Hold
2,665
– – ﹤0.01% 3505
2018
Q2 		$4K Buy
2,665
+1,538
+136% +$2.36K ﹤0.01% 3436
2018
Q1 		$3K Hold
1,127
– – ﹤0.01% 3470
2017
Q4 		$3K Sell
1,127
-208
-16% -$526 ﹤0.01% 3521
2017
Q3 		$5K Hold
1,335
– – ﹤0.01% 3464
2017
Q2 		$5K Hold
1,335
– – ﹤0.01% 3471
2017
Q1 		$5K Hold
1,335
– – ﹤0.01% 3372
2016
Q4 		$6K Hold
1,335
– – ﹤0.01% 3252
2016
Q3 		$6K Hold
1,335
– – ﹤0.01% 3193
2016
Q2 		$3K Buy
+1,335
New +$4.83K ﹤0.01% 3428
2016
Q1 		– Sell
-1,359
Closed -$5K – 4453
2015
Q4 		$5K Buy
+1,359
New +$6.26K ﹤0.01% 3036

IFP Advisors's AST Position: Q1 2019 in Review

IFP Advisors sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q1 2019, closing a stake of 1,518 shares — an estimated $1K sold.

IFP Advisors first reported a position in AST in Q4 2015 and held it in 12 quarters. The position peaked at $6K in Q4 2016. 0 funds tracked by Wall St. Rank hold AST as of Q1 2019.

  • IFP Advisors reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q1 2019 after selling out during the quarter.
  • IFP Advisors sold 1,518 Asterias Biotherapeutics Inc. Series A shares in Q1 2019, an estimated $1K.
  • IFP Advisors first reported a position in Asterias Biotherapeutics Inc. Series A in Q4 2015 and held it in 12 quarters.
  • IFP Advisors's Asterias Biotherapeutics Inc. Series A position peaked at $6K in Q4 2016.
  • 0 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q1 2019.

Based on IFP Advisors's 13F filing for Q1 2019, filed 15 May 2019.